Quick Search

Keyword
Title
Author
Seller Id
Advanced Search
 
 

Find us on:

 
Gift Certificate

 
 
Other
       Tell a Friend
Add to Shopping Cart
The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders, Elaine A. Moore
Stock Image
Author Name:    Elaine A. Moore

Title:   The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

Binding:   PAPERBACK

Book Condition:   New

Publisher:    McFarland 

ISBN Number:   0786437154 / 9780786437153

Seller ID:   ING9780786437153

0786437154 Special order direct from the distributor

More Description

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).

Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.



Price = 50.62 CDN
Add to Shopping Cart

cookie